By Claudio Ronco, MD, Divisione di Nefrologia, Ospedale San Bortolo, Vicenza, Italy; Rinaldo Bellomo, MBBS(Hons), MD, FRACP, FCCP, Chairman, Australian and New Zealand Intensive Care Society Clinical Trials Group; Director of Intensive Care Research, Department of Intensive Care, Austin & Repatriation Medical Centre, Melbourne, Victoria, Australia; and John Kellum, MD, UPMC Presbyterian, Pittsburgh, PA |